norethindrone and Disease

Topics: Amenorrhea; Asia; Asia, Eastern; Biology; Blood; Blood Coagulation; Carbohydrates; China; Contraception; Contraception Behavior; Contraceptive Agents; Contraceptive Agents, Female; Contraceptives, Oral, Hormonal; Developing Countries; Disease; Endocrine System; Endometrium; Family Planning Services; Fibrinolysis; Genitalia; Genitalia, Female; Glucose; Hemorrhage; Hormones; Injections; International Agencies; Lipids; Medroxyprogesterone Acetate; Megestrol Acetate; Menstruation Disturbances; Metabolism; Norethindrone; Organizations; Ovulation; Patient Acceptance of Health Care; Physiology; Progesterone; Progestins; Reproduction; Research; Signs and Symptoms; United Nations; Urogenital System; Uterus; World Health Organization

Topics: Chlormadinone Acetate; Contraception; Contraceptive Agents, Female; Contraceptives, Oral; Contraceptives, Oral, Combined; Disease; Ethynodiol Diacetate; Family Planning Services; Glucose; Lynestrenol; Mestranol; Norethindrone; Norethynodrel; Research; Vagina; Vaginitis

Topics: Acne Vulgaris; Biology; Contraception; Contraceptive Agents; Contraceptive Agents, Female; Contraceptives, Oral; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Dermatitis; Disease; Ethynodiol Diacetate; Family Planning Services; Mestranol; Norethindrone; Norethynodrel; Physiology; Skin

Topics: Biology; Blood; Blood Coagulation; Contraception; Contraceptive Agents; Contraceptive Agents, Female; Contraceptives, Oral; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Disease; Embolism; Ethinyl Estradiol; Family Planning Services; Lynestrenol; Mestranol; Norethindrone; Physiology; Research; Statistics as Topic; Thromboembolism; Vascular Diseases

Topics: Adrenal Cortex; Age Factors; Biology; Blood; Body Weight; Contraception; Contraceptive Agents; Contraceptive Agents, Female; Contraceptives, Oral; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Disease; Endocrine Glands; Endocrine System; Endometrium; Ethinyl Estradiol; Family Planning Services; Genitalia; Genitalia, Female; Liver; Lynestrenol; Mestranol; Norethindrone; Ovary; Parity; Patient Acceptance of Health Care; Physiology; Progesterone; Prospective Studies; Research; Statistics as Topic; Transcortin; Urogenital System; Uterus; Vagina; Vaginitis

Topics: Amenorrhea; Biology; Contraception; Contraceptive Agents; Contraceptive Agents, Female; Corpus Luteum; Disease; Endometrium; Family Planning Services; Genitalia; Genitalia, Female; Histology; Injections; Medroxyprogesterone Acetate; Menstrual Cycle; Menstruation Disturbances; Norethindrone; Ovary; Ovulation; Physiology; Research; Urogenital System; Uterus; Vagina; Vaginitis

Topics: Contraception; Contraceptive Agents; Contraceptive Agents, Female; Contraceptives, Oral; Disease; Dysmenorrhea; Family Planning Services; Menstruation Disturbances; Norethindrone; Premenstrual Syndrome; Research

Topics: Amenorrhea; Anovulation; Asia; Biology; Contraception; Contraceptive Agents; Contraceptive Agents, Female; Contraceptives, Oral; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Demography; Developing Countries; Disease; Ethinyl Estradiol; Family Planning Services; Fertility; Genitalia; Genitalia, Female; India; Liver; Menstruation Disturbances; Mestranol; Metabolism; Norethindrone; Norethynodrel; Ovary; Patient Acceptance of Health Care; Physiology; Population; Population Dynamics; Research; Sexual Behavior; Steroids; Urogenital System

Topics: Amenorrhea; Biology; Contraception; Contraceptive Agents; Contraceptive Agents, Female; Contraceptives, Oral; Disease; Endocrine System; Family Planning Services; Hemorrhage; Hormones; Injections; Intrauterine Devices; Lactation; Levonorgestrel; Menstrual Cycle; Menstruation; Menstruation Disturbances; Norethindrone; Physiology; Pregnancy; Progesterone; Progestins; Reproduction; Signs and Symptoms

Topics: Contraception; Contraceptive Agents; Contraceptive Agents, Female; Disease; Evaluation Studies as Topic; Family Planning Services; Genitalia, Female; Hemorrhage; Menstruation Disturbances; Norethindrone; Signs and Symptoms; Urogenital System

Topics: Asia; Asia, Southeastern; Biology; Contraception; Contraception Behavior; Contraceptive Agents; Contraceptive Agents, Female; Contraceptives, Oral; Data Collection; Developing Countries; Disease; Endocrine System; Family Planning Services; Hemorrhage; Hormones; Levonorgestrel; Malaysia; Menstruation Disturbances; Metrorrhagia; Norethindrone; Patient Acceptance of Health Care; Physiology; Research; Sampling Studies; Signs and Symptoms; Statistics as Topic

Topics: Age Factors; Behavior; Biology; Blood; Blood Coagulation; Carbohydrates; Cardiovascular System; Cause of Death; Cholesterol; Contraception; Contraceptive Agents; Contraceptive Agents, Female; Contraceptives, Oral, Hormonal; Demography; Disease; Endocrine System; Ethinyl Estradiol; Family Planning Services; Glucose; Hormones; Levonorgestrel; Lipids; Metabolism; Mortality; Norethindrone; Organic Chemicals; Physiology; Population; Population Characteristics; Reproductive Control Agents; Smoking; Social Behavior; Vascular Diseases

Topics: Biology; Blood; Blood Coagulation; Blood Pressure; Carbohydrates; Cholesterol; Contraception; Contraceptive Agents; Contraceptive Agents, Female; Contraceptives, Oral; Contraceptives, Oral, Combined; Disease; Endometrium; Estradiol; Estrogens; Family Planning Services; Genitalia; Genitalia, Female; Glucose; Hormones; Levonorgestrel; Lipids; Menstruation Disturbances; Metabolism; Norethindrone; Physiology; Reproductive Control Agents; Urogenital System; Uterus

Topics: Biology; Carbohydrates; Chemical Phenomena; Chemistry; Cholesterol; Contraception; Contraceptive Agents; Contraceptive Agents, Female; Contraceptives, Oral; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Cyproterone Acetate; Disease; Endocrine System; Ethinyl Estradiol; Ethynodiol Diacetate; Family Planning Services; Glucose; Hormone Antagonists; Hormones; Levonorgestrel; Lipids; Lynestrenol; Metabolism; Norethindrone; Norethynodrel; Norgestrel; Organic Chemicals; Physiology; Reproductive Control Agents

Topics: Anthropometry; Biology; Blood; Blood Pressure; Body Weight; Carbohydrates; Child Development; Contraception; Contraceptive Agents; Contraceptive Agents, Female; Contraceptives, Oral; Contraceptives, Oral, Combined; Developed Countries; Disease; Double-Blind Method; Dysmenorrhea; Epidemiologic Methods; Ethinyl Estradiol; Europe; Evaluation Studies as Topic; Family Planning Services; France; Genitalia; Genitalia, Female; Glucose; Growth; Hemorrhage; Hormones; Menstrual Cycle; Menstruation; Menstruation Disturbances; Metabolism; Metrorrhagia; Norethindrone; Physiology; Premenstrual Syndrome; Reproduction; Reproductive Control Agents; Research; Research Design; Signs and Symptoms; Urogenital System

Topics: Americas; Biology; Blood; Blood Pressure; Body Weight; Clinical Laboratory Techniques; Clinical Trials as Topic; Contraception; Contraception Behavior; Contraceptive Agents; Contraceptive Agents, Female; Contraceptives, Oral; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Developing Countries; Diagnosis; Disease; Ethinyl Estradiol; Evaluation Studies as Topic; Family Planning Services; Hemorrhage; Latin America; Levonorgestrel; Lipids; Menstrual Cycle; Menstruation; Metrorrhagia; Mexico; Norethindrone; North America; Patient Acceptance of Health Care; Physiology; Reproduction; Research; Signs and Symptoms

Topics: Amenorrhea; Biology; Contraception; Contraceptive Agents; Contraceptive Agents, Female; Disease; Evaluation Studies as Topic; Family Planning Services; Hemorrhage; Injections; Lactation; Menstruation Disturbances; Metrorrhagia; Norethindrone; Physiology; Pregnancy; Research; Signs and Symptoms

Topics: Amenorrhea; Biology; Contraception; Contraceptive Agents; Contraceptive Agents, Female; Disease; Evaluation Studies as Topic; Family Planning Services; Hemorrhage; Injections; Lactation; Menstruation Disturbances; Metrorrhagia; Norethindrone; Physiology; Pregnancy; Research; Signs and Symptoms

Topics: Adult; Aged; Biology; Blood Coagulation; Contraception; Contraceptive Agents; Contraceptive Agents, Female; Contraceptives, Oral; Disease; Embolism; Evaluation Studies as Topic; Family Planning Services; Female; Humans; Hypertension; Middle Aged; Norethindrone; Physiology; Research; Scleroderma, Systemic; Skin; Thromboembolism; Thrombosis; Vascular Diseases

Topics: Amenorrhea; Blood Pressure; Body Weight; Contraception; Contraception Behavior; Contraceptive Agents; Contraceptive Agents, Female; Disease; Family Planning Services; Hemorrhage; Injections; Menstruation; Menstruation Disturbances; Norethindrone; Pain; Patient Acceptance of Health Care; Reproduction; Reproductive Control Agents; Research

Topics: Anovulation; Biology; Contraception; Contraception Behavior; Contraceptive Agents; Contraceptive Agents, Female; Contraceptives, Oral; Developed Countries; Diagnosis; Disease; Endocrine System; Endoscopy; England; Ethynodiol Diacetate; Europe; Family Planning Services; Genitalia; Genitalia, Female; Hormones; Levonorgestrel; Norethindrone; Ovarian Cysts; Ovary; Physical Examination; Physiology; Progesterone Congeners; Sexual Behavior; Ultrasonics; United Kingdom; Urogenital System

Topics: Age Factors; Behavior; Biology; Breast Feeding; Contraception; Contraceptive Agents; Contraceptive Agents, Female; Contraceptives, Oral; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Contraceptives, Postcoital; Demography; Disease; Embolism; Endocrine System; Ethinyl Estradiol; Family Planning Services; Health; Heart Diseases; Hormones; Hypertension; Infant Nutritional Physiological Phenomena; Levonorgestrel; Liver Diseases; Mestranol; Morbidity; Mortality; Norethindrone; Nutritional Physiological Phenomena; Physiology; Population; Population Characteristics; Population Dynamics; Progesterone; Progestins; Smoking; Thromboembolism; Vascular Diseases

Topics: Biology; Communication; Consumer Product Safety; Contraception; Contraceptive Agents; Contraceptive Agents, Female; Contraceptives, Oral; Delivery of Health Care; Demography; Desogestrel; Developed Countries; Disease; Embolism; Europe; Evaluation Studies as Topic; Family Planning Services; Geography; Health; Health Personnel; Knowledge; Levonorgestrel; Norethindrone; Population; Public Health; Residence Characteristics; Risk Assessment; Risk Factors; Safety; Thromboembolism; Thrombosis; United Kingdom; Vascular Diseases

Topics: Amenorrhea; Body Temperature; Cells; Cervix Mucus; Contraception; Contraceptive Agents; Contraceptive Agents, Female; Contraceptives, Oral; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Disease; Dysmenorrhea; Endometrium; Ethinyl Estradiol; Family Planning Services; Hemorrhage; Infertility; Menstruation Disturbances; Norethindrone; Reproduction; Research; Signs and Symptoms; Vagina

Topics: Biology; Contraception; Contraceptive Agents; Contraceptive Agents, Female; Contraceptives, Oral; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Disease; Ethinyl Estradiol; Family Planning Services; Liver; Liver Diseases; Lynestrenol; Mestranol; Norethindrone; Physiology

Topics: Breast; Breast Neoplasms; Contraception; Contraceptive Agents; Contraceptive Agents, Female; Contraceptives, Oral; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Dimethisterone; Disease; Ethinyl Estradiol; Family Planning Services; Lactation; Neoplasms; Norethindrone; Puerperal Disorders; Research

Topics: Blood Coagulation; Contraception; Contraceptive Agents; Contraceptive Agents, Female; Contraceptives, Oral; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Digestive System; Disease; Embolism; Ethinyl Estradiol; Family Planning Services; Hemorrhage; Injections; Lynestrenol; Medroxyprogesterone Acetate; Menstrual Cycle; Menstruation; Mestranol; Metrorrhagia; Nausea; Norethindrone; Norethynodrel; Pseudopregnancy; Reproduction; Signs and Symptoms; Thromboembolism; Vascular Diseases

Topics: Abortion, Spontaneous; Contraception; Contraceptive Agents; Contraceptive Agents, Female; Disease; Family Planning Services; Infertility; Menstruation Disturbances; Norethindrone; Pregnancy; Premenstrual Syndrome; Progesterone Congeners; Reproduction; Research

Topics: Biology; Contraception; Contraceptive Agents; Contraceptive Agents, Female; Disease; Dysmenorrhea; Endometrium; Family Planning Services; Genitalia; Genitalia, Female; Infertility; Lynestrenol; Menstruation Disturbances; Norethindrone; Pelvic Inflammatory Disease; Physiology; Reproduction; Tissue Adhesions; Urogenital System; Uterus

Topics: Age Factors; Amenorrhea; Contraception; Contraceptive Agents; Contraceptive Agents, Female; Diagnosis; Disease; Family Planning Services; Hemorrhage; Injections; Intrauterine Devices; Medroxyprogesterone Acetate; Menstruation Disturbances; Norethindrone; Patient Acceptance of Health Care; Retention, Psychology; Therapeutics

Topics: Animals, Laboratory; Contraception; Contraceptive Agents; Contraceptive Agents, Female; Disease; Endometrial Neoplasms; Family Planning Services; Injections; International Agencies; Lactation; Medroxyprogesterone Acetate; Menstruation Disturbances; Neoplasms; Norethindrone; Organizations; Research; Steroids; Uterine Cervical Neoplasms

Topics: Anatomy; Belgium; Biology; Contraception; Contraceptive Agents; Contraceptive Agents, Female; Contraceptives, Oral; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Developed Countries; Disease; Endocrine System; Endometrial Neoplasms; Endometrium; Europe; Family Planning Services; Genitalia; Genitalia, Female; Histology; Hormones; Mestranol; Neoplasms; Norethindrone; Physiology; Reproductive Control Agents; Risk Factors; Urogenital System; Uterus

Topics: Americas; Arterial Occlusive Diseases; Arteriosclerosis; Biology; Contraception; Contraceptive Agents; Contraceptive Agents, Female; Contraceptives, Oral; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Developed Countries; Disease; Ethinyl Estradiol; Family Planning Services; Levonorgestrel; Lipids; Norethindrone; Norgestrel; North America; Physiology; United States; Vascular Diseases

Topics: Americas; Breast Neoplasms; Contraception; Contraceptive Agents; Contraceptive Agents, Female; Developed Countries; Disease; Endometrial Neoplasms; Evaluation Studies as Topic; Family Planning Services; Government Agencies; Health Services Accessibility; Injections; Medroxyprogesterone Acetate; Menstruation Disturbances; Neoplasms; Norethindrone; North America; Organizations; United States; United States Food and Drug Administration; United States Public Health Service

Topics: Acromegaly; Adolescent; Adrenocorticotropic Hormone; Adult; Age Factors; Animals; Biological Assay; Chorionic Gonadotropin; Disease; Estrogens; Female; Feminization; Follicle Stimulating Hormone; Gonads; Guinea Pigs; Humans; Immune Sera; Iodine Isotopes; Kinetics; Luteinizing Hormone; Male; Menopause; Menstruation; Mestranol; Middle Aged; Norethindrone; Pituitary Diseases; Pituitary Gland; Puberty; Radioimmunoassay; Testosterone; Thyroid Diseases; Thyrotropin